Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study-Reference-Cited by-同舟云学术

Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study

Published:2016-01-28 Issue:3 Volume:21 Page:217-228
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Viecelli Andrea K¹,Pascoe Elaine M²,Polkinghorne Kevan R³⁴⁵,Hawley Carmel M¹²,Paul-Brent Peta-Anne²,Badve Sunil V²⁶,Cass Alan⁷,Johnson David W¹²,Kerr Peter G³⁵,Mori Trevor A⁸,Scaria Anish²,Hooi Seong L⁹,Ong Meng L¹⁰,Irish Ashley B⁸¹¹,

Affiliation:

1. Department of Nephrology; Princess Alexandra Hospital; Brisbane Queensland Australia

2. Australasian Kidney Trials Network; School of Medicine; University of Queensland; Brisbane Queensland Australia

3. Department of Nephrology; Monash Medical Centre; Melbourne Victoria Australia

4. School of Public Health and Preventive Medicine; Monash University; Melbourne Victoria Australia

5. Department of Medicine; Monash University; Melbourne Victoria Australia

6. Department of Nephrology; St George Hospital; Sydney New South Wales Australia

7. Menzies School of Health Research; Charles Darwin University; Darwin Australia

8. School of Medicine and Pharmacology; University of Western Australia; Perth Western Australia Australia

9. Department of Medicine and Haemodialysis Unit; Hospital Sultanah Aminah; Johor Bahru Malaysia

10. Department of Nephrology; Penang Hospital; Georgetown Malaysia

11. Department of Nephrology; Fiona Stanley Hospital; Perth Western Australia Australia

Funder

National Health and Medical Research Council Project Grant

Australian and New Zealand Clinical Trials Register

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nep.12573/fullpdf

Reference29 articles.

1. NKF-KDOQI Guidelines Clinical Practice Guidelines and Clinical Practice Recommendations 2006 https://www.kidney.org/sites/default/files/docs/12-50-0210_jag_dcp_guidelines-hd_oct06_sectiona_ofc.pdf

2. Russell C Polkinghorne K Kidney Health Australia CARI Guidelines. Pre-operative Examination of the Vessels - Diagnostic Evaluation Prior to Permanent Access Selection 2012 http://www.cari.org.au/Dialysis/dialysis%20vascular%20access/Pre-op_examination_of_vessels.pdf2012

3. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology;Jindal;J. Am. Soc. Nephrol.,2006

4. Fistula First Breakthrough Initiative (FFBI): lessons about arteriovenous fistula prevalence goals;Howard;Am. J. Kidney Dis.,2013

5. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions;Allon;Kidney Int.,2002

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protection against Incidences of Serious Cardiovascular Events Study with daily fish oil supplementation in dialysis patients (PISCES): protocol for a randomised controlled trial;BMJ Open;2024-01

2. Marine-derived n-3 fatty acids therapy for stroke;Cochrane Database of Systematic Reviews;2022-06-29

3. Antiplatelet agents for chronic kidney disease;Cochrane Database of Systematic Reviews;2022-02-28

4. Dietary habits in Australian, New Zealand and Malaysian patients with end stage kidney failure: A pre‐specified cross‐sectional study of the FAVOURED trial participants;Journal of Human Nutrition and Dietetics;2022-01-20

5. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts;Cochrane Database of Systematic Reviews;2021-07-23